CVE-2017-1271

Description

IBM Security Guardium 9.0, 9.1, and 9.5 supports interaction between multiple actors and allows those actors to negotiate which algorithm should be used as a protection mechanism such as encryption or authentication, but it does not select the strongest algorithm that is available to both parties. IBM X-Force ID: 124746.

Category

7.5
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.06%
Vendor Advisory ibm.com Vendor Advisory ibmcloud.com
Affected: IBM Security Guardium
Published at:
Updated at:

References

Link Tags
http://www.ibm.com/support/docview.wss?uid=swg22010435 vendor advisory issue tracking
http://www.securitytracker.com/id/1039961 third party advisory vdb entry
http://www.securityfocus.com/bid/102034 third party advisory vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/124746 vendor advisory vdb entry issue tracking

Frequently Asked Questions

What is the severity of CVE-2017-1271?
CVE-2017-1271 has been scored as a high severity vulnerability.
How to fix CVE-2017-1271?
To fix CVE-2017-1271, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-1271 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-1271 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-1271?
CVE-2017-1271 affects IBM Security Guardium.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.